中国血管外科杂志(电子版)
中國血管外科雜誌(電子版)
중국혈관외과잡지(전자판)
CHINESE JOURNAL OF VASCULAR SURGERY(ELECTRONIC VERSION)
2013年
2期
112-115
,共4页
李文东%李晓强%桑宏飞%孟庆友%钱爱民
李文東%李曉彊%桑宏飛%孟慶友%錢愛民
리문동%리효강%상굉비%맹경우%전애민
SilverHawk%下肢动脉硬化闭塞症%支架内再狭窄
SilverHawk%下肢動脈硬化閉塞癥%支架內再狹窄
SilverHawk%하지동맥경화폐새증%지가내재협착
SilverHawk%Arteriosclerosis occlusion%In-stent restenosis
目的评价 SilverHawk 斑块切除系统在股浅动脉硬化性闭塞症支架内再狭窄治疗中的安全性及近期疗效。方法2011年4月~2012年2月采用 SilverHawk 斑块切除系统治疗下肢动脉硬化闭塞症支架置入术后支架内再狭窄患者共5例(5条肢体)。Rutherford 分级3~5级;TASC Ⅱ分型:A 型3例、B 型1例、C 型1例。除临床症状外,还采用彩超或 CT 血管造影方法对管腔通畅情况进行评估随访。结果本组5例手术均成功,无死亡病例。患者术后症状均较术前减轻,踝肱指数由术前的0.38±0.09上升至0.81±0.09。5例患者获得随访,随访时间8~17[平均(11.4±3.1)]个月;1例在术后6个月时出现再狭窄,行左大腿截肢术;余4例患者随访期内患肢股浅动脉支架内血流通畅。结论SilverHawk 斑块切除系统在股浅动脉支架内再狭窄的治疗中安全有效,近期效果满意。
目的評價 SilverHawk 斑塊切除繫統在股淺動脈硬化性閉塞癥支架內再狹窄治療中的安全性及近期療效。方法2011年4月~2012年2月採用 SilverHawk 斑塊切除繫統治療下肢動脈硬化閉塞癥支架置入術後支架內再狹窄患者共5例(5條肢體)。Rutherford 分級3~5級;TASC Ⅱ分型:A 型3例、B 型1例、C 型1例。除臨床癥狀外,還採用綵超或 CT 血管造影方法對管腔通暢情況進行評估隨訪。結果本組5例手術均成功,無死亡病例。患者術後癥狀均較術前減輕,踝肱指數由術前的0.38±0.09上升至0.81±0.09。5例患者穫得隨訪,隨訪時間8~17[平均(11.4±3.1)]箇月;1例在術後6箇月時齣現再狹窄,行左大腿截肢術;餘4例患者隨訪期內患肢股淺動脈支架內血流通暢。結論SilverHawk 斑塊切除繫統在股淺動脈支架內再狹窄的治療中安全有效,近期效果滿意。
목적평개 SilverHawk 반괴절제계통재고천동맥경화성폐새증지가내재협착치료중적안전성급근기료효。방법2011년4월~2012년2월채용 SilverHawk 반괴절제계통치료하지동맥경화폐새증지가치입술후지가내재협착환자공5례(5조지체)。Rutherford 분급3~5급;TASC Ⅱ분형:A 형3례、B 형1례、C 형1례。제림상증상외,환채용채초혹 CT 혈관조영방법대관강통창정황진행평고수방。결과본조5례수술균성공,무사망병례。환자술후증상균교술전감경,과굉지수유술전적0.38±0.09상승지0.81±0.09。5례환자획득수방,수방시간8~17[평균(11.4±3.1)]개월;1례재술후6개월시출현재협착,행좌대퇴절지술;여4례환자수방기내환지고천동맥지가내혈류통창。결론SilverHawk 반괴절제계통재고천동맥지가내재협착적치료중안전유효,근기효과만의。
Objective To evaluate the safety and efficacy of SilverHawk atherectomy device in the treatment of the in-stent restenosis in the superficial femoral artery(SFA) . Methods From Apr. 2011 to Feb. 2012,5 patients with in-stent restenosis (Rutherford score of 3~5,TASC Ⅱ classification:TASC A in 3 cases, TASC B in l case ,TASC C in 1 Case) were treated by SilverHawk atherectomy devices. All the patients were diagnosed via low-extremity artery CTA or Doppler ultrasonography. Results The overall technical success rate was 100 % (5/ 5),with no death. All of the symptoms were relieved. The ABI increased from 0.38±0.09 to 0.81±0.09. All the patients were followed up for 8~17 (mean, 11.4±3.1) months. One patient received leg amputation 6 months after surgery because of restenosis. The patency rate of SFA in the other 5 patients was high. Conclusion It is safe and effective to treat in-stent restenosis of SFA using SilverHawk atherectomy device .The early results were satisfied.